804 studies found for:    Open Studies | "Prostatic Neoplasms"
Show Display Options
RSS Create an RSS feed from your search for:
Open Studies | "Prostatic Neoplasms"
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting A Study to Describe Patterns of Care and Outcomes of Men Who Are at High Risk After Experiencing Biochemical Failure Following Definitive Prostate Cancer Therapy, Men With Castration-resistant Prostrate Cancer and Men With Metastatic Prostate Cancer
Conditions: Prostate Cancer;   Metastatic Prostate Cancer;   Castration-resistant Prostate Cancer
Intervention:
2 Recruiting Lyophilized Black Raspberry in Treating Patients With Prostate Cancer Undergoing Surgery
Conditions: Stage I Prostate Cancer;   Stage IIA Prostate Cancer;   Stage IIB Prostate Cancer;   Stage III Prostate Cancer;   Stage IV Prostate Cancer
Interventions: Drug: lyophilized black raspberry lozenge;   Other: laboratory biomarker analysis;   Dietary Supplement: dietary intervention;   Procedure: therapeutic conventional surgery;   Procedure: quality-of-life assessment;   Other: questionnaire administration
3 Recruiting Docetaxel Plus Lycopene in Castration Resistant, Chemotherapy-Naïve Prostate Cancer Patients
Conditions: Adenocarcinoma of the Prostate;   Recurrent Prostate Cancer;   Stage I Prostate Cancer;   Stage IIA Prostate Cancer;   Stage IIB Prostate Cancer;   Stage III Prostate Cancer
Interventions: Drug: Docetaxel;   Dietary Supplement: Lycopene
4 Not yet recruiting Phase 1-2 Study of Onapristone in Patients With Advanced Castration-resistant Prostate Cancer
Conditions: Prostate Cancer;   Metastatic Prostate Cancer;   Androgen-independent Prostate Cancer;   Recurrent Prostate Cancer
Intervention: Drug: onapristone
5 Recruiting Cabazitaxel Plus Prednisone With Octreotide For Castration-Resistant Prostate Cancer (CRPC) Previously Treated With Docetaxel
Conditions: Diarrhea;   Hormone-resistant Prostate Cancer;   Recurrent Prostate Cancer;   Stage I Prostate Cancer;   Stage IIA Prostate Cancer;   Stage IIB Prostate Cancer;   Stage III Prostate Cancer;   Stage IV Prostate Cancer
Interventions: Drug: cabazitaxel;   Drug: prednisone;   Drug: octreotide pamoate;   Other: questionnaire administration;   Drug: octreotide acetate
6 Recruiting Cabozantinib in Treating Men With Castration-Resistant Prostate Cancer
Conditions: Adenocarcinoma of the Prostate;   Castration-resistant Prostate Cancer;   Recurrent Prostate Cancer;   Stage III Prostate Cancer;   Stage IV Prostate Cancer
Interventions: Drug: cabozantinib-s-malate;   Other: laboratory biomarker analysis
7 Recruiting High-Dose Stereotactic Radiation for Prostate Cancer
Conditions: Adenocarcinoma of the Prostate;   Recurrent Prostate Cancer;   Stage I Prostate Cancer;   Stage IIA Prostate Cancer;   Stage IIB Prostate Cancer;   Stage III Prostate Cancer
Interventions: Radiation: stereotactic body radiation therapy;   Procedure: quality-of-life assessment;   Other: laboratory biomarker analysis
8 Recruiting Study of Cabozantinib in Combination With Abiraterone in Chemotherapy-Naïve Subjects With Bone-Metastatic Castration-Resistant Prostate Cancer
Conditions: Prostate Cancer;   Castration Resistant Prostate Cancer;   Prostatic Neoplasms
Interventions: Drug: cabozantinib;   Drug: abiraterone;   Drug: prednisone
9 Recruiting Study of Cabozantinib (XL184) Versus Mitoxantrone Plus Prednisone in Men With Previously Treated Symptomatic Castration-resistant Prostate Cancer
Conditions: Prostate Cancer;   Castration Resistant Prostate Cancer;   Pain;   Prostatic Neoplasms
Interventions: Drug: cabozantinib;   Drug: mitoxantrone;   Drug: prednisone
10 Recruiting A Pilot Study to Enhance F18 FDG-PET Imaging of Prostate Cancers With the Metabolic Inhibitor Ranolazine
Conditions: Adenocarcinoma of the Prostate;   Bone Metastases;   Soft Tissue Metastases;   Stage IIA Prostate Cancer;   Stage IIB Prostate Cancer;   Stage III Prostate Cancer;   Stage IV Prostate Cancer
Intervention: Drug: Ranolazine
11 Unknown  Study of Antioxidants on Prostate Tumors in Men Undergoing Radical Prostatectomy for Prostate Cancer
Conditions: Cancer of the Prostate;   Prostate Cancer;   Prostatic Neoplasms
Interventions: Dietary Supplement: Lycopene, Vitamin D3, Selenium, Green Tea Extract, Vitamin E;   Drug: Placebo
12 Recruiting Temsirolimus and Vorinostat in Treating Patients With Metastatic Prostate Cancer
Conditions: Prostate Cancer;   Adenocarcinoma of the Prostate;   Hormone-resistant Prostate Cancer;   Recurrent Prostate Cancer;   Stage IV Prostate Cancer
Interventions: Drug: vorinostat;   Drug: temsirolimus;   Other: laboratory biomarker analysis;   Procedure: positron emission tomography/computed tomography
13 Recruiting Doxorubicin-GnRH Agonist Conjugate AEZS-108 in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer
Conditions: Prostate Cancer;   Hormone-resistant Prostate Cancer;   Recurrent Prostate Cancer;   Stage IV Prostate Cancer
Interventions: Other: laboratory biomarker analysis;   Other: questionnaire administration;   Drug: doxorubicin-GnRH agonist conjugate AEZS-108
14 Recruiting Genistein in Treating Patients With Prostate Cancer
Conditions: Adenocarcinoma of the Prostate;   Recurrent Prostate Cancer;   Stage I Prostate Cancer;   Stage II Prostate Cancer;   Stage III Prostate Cancer
Interventions: Dietary Supplement: genistein;   Other: placebo;   Procedure: therapeutic conventional surgery
15 Recruiting High-Dose Rate Brachytherapy and Stereotactic Body Radiation Therapy in Treating Patients With Prostate Cancer
Conditions: Prostate Cancer;   Adenocarcinoma of the Prostate;   Recurrent Prostate Cancer;   Stage IIA Prostate Cancer;   Stage IIB Prostate Cancer
Interventions: Radiation: Brachytherapy;   Radiation: Stereotactic Body Radiation Therapy;   Procedure: Quality-of-life assessment;   Other: Questionnaire administration
16 Not yet recruiting Enzalutamide, Radiation Therapy and Hormone Therapy in Treating Patients With Intermediate or High-Risk Prostate Cancer
Conditions: Adenocarcinoma of the Prostate;   Recurrent Prostate Cancer;   Stage IIB Prostate Cancer;   Stage III Prostate Cancer;   Stage IV Prostate Cancer
Interventions: Drug: Enzalutamide;   Drug: Goserelin acetate;   Drug: Leuprolide acetate;   Radiation: Radiation therapy
17 Recruiting Cholecalciferol Supplement in Treating Patients With Localized Prostate Cancer Undergoing Observation
Conditions: Adenocarcinoma of the Prostate;   Stage I Prostate Cancer;   Stage II Prostate Cancer;   Stage III Prostate Cancer;   Stage IV Prostate Cancer
Interventions: Dietary Supplement: cholecalciferol;   Drug: placebo administration;   Other: active surveillance;   Other: laboratory biomarker analysis
18 Recruiting Metformin Hydrochloride in Treating Patients With Prostate Cancer Undergoing Surgery
Conditions: Adenocarcinoma of the Prostate;   Recurrent Prostate Cancer;   Stage I Prostate Cancer;   Stage IIA Prostate Cancer;   Stage IIB Prostate Cancer
Interventions: Drug: metformin hydrochloride;   Other: placebo;   Other: laboratory biomarker analysis
19 Recruiting Sipuleucel-T Manufacturing Demonstration Study
Conditions: Cancer of Prostate;   Cancer of the Prostate;   Neoplasms, Prostate;   Neoplasms, Prostatic;   Prostate Cancer;   Prostate Neoplasms;   Prostatic Cancer
Intervention: Biological: sipuleucel-T
20 Recruiting Anti-OX40, Cyclophosphamide (CTX) and Radiation in Patients With Progressive Metastatic Prostate Cancer
Conditions: Metastatic Prostate Cancer;   Cancer of the Prostate;   Prostate Cancer
Interventions: Drug: Anti-OX40;   Radiation: Radiation;   Drug: Cyclophosphamide

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years